SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-011253
Filing Date
2021-03-05
Accepted
2021-03-05 16:00:44
Documents
13
Period of Report
2021-03-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K PROXY VOTE enta-8k_20210302.htm   iXBRL 8-K 89526
2 EX-10.1 enta-ex101_37.htm EX-10.1 116814
  Complete submission text file 0001564590-21-011253.txt   356691

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA enta-20210302.xsd EX-101.SCH 5768
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20210302_lab.xml EX-101.LAB 18714
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20210302_pre.xml EX-101.PRE 11169
6 EXTRACTED XBRL INSTANCE DOCUMENT enta-8k_20210302_htm.xml XML 3400
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35839 | Film No.: 21718424
SIC: 2834 Pharmaceutical Preparations